Ledger.Open graph →
SEC Form D · filed June 12, 2015

Kanyos Bio, Inc

Offering
$10.4M
Sold
$10.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Harry Welten · SAN FRANCISCO, CADirectorThomas Woiwode · SAN FRANCISCO, CADirectorAndre Mueller · SAN FRANCISCO, CADirectorJeffrey Hubbell · SAN FRANCISCO, CAExec · DirectorJack Nielsen · SAN FRANCISCO, CADirectorOscar Buset · SAN FRANCISCO, CAExecFlorent Gros · SAN FRANCISCO, CADirectorAlan Hahn · Aurora, COExecAnirvan Banerji · New York, NYExec · DirectorLakshman Achuthan · New York, NYDirectorSonian Capital Management, L.L.C · Boston, MADirectorDaniel Rossett · Atherton, CAExec · DirectorIan Pilgrim · GRAND CAYMAN, Cayman IslandsExec · DirectorBen Sampson · Mount Shasta, CADirectorMark Pacchini · Elmurst, ILDirectorThomas D. Kiley · Mill Valley, CADirectorThomas Quinn · King of Prussia, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗